Page 2 - 06- Cirrhosis of the Liver
P. 2

CIRRHOSIS OF THE LIVER
               Liam P. Burke, MD



                      BASICS


               DESCRIPTION
               A chronic disease with inflammation, necrosis, fibrosis, hepatocellular dysfunction, and vascular
               remodeling potentially leading to liver failure and/or cancer

               EPIDEMIOLOGY
                  Predominant age at diagnosis: 40 to 60 years old
                  Predominant sex: male > female; more women with cirrhosis from alcohol abuse
                  Liver disease and cirrhosis are the 9th leading causes of death among U.S. adult males; 12th
                  overall

               ETIOLOGY AND PATHOPHYSIOLOGY
                  Chronic hepatitis C virus (HCV) (26%)
                  Alcohol abuse (21%)
                  Nonalcoholic steatohepatitis (NASH)/obesity (~10%)
                  Hepatitis B virus (HBV) plus hepatitis D infection (15%)
                  Other: hemochromatosis, autoimmune hepatitis, primary biliary cirrhosis, secondary biliary
                  cirrhosis, biliary atresia, idiopathic biliary fibrosis, primary sclerosing cholangitis, Wilson
                  disease, α -antitrypsin deficiency, granulomatous disease (e.g., sarcoidosis); drug-induced
                           1
                  liver disease (e.g., methotrexate, α-methyldopa, amiodarone); venous outflow obstruction
                  (e.g., Budd-Chiari syndrome, veno-occlusive disease); chronic right-sided heart failure;
                  tricuspid regurgitation; and rare genetic, metabolic, and infectious causes
                  Hepatocellular injury results in cellular hyperplasia (regenerating nodules), fibrous changes,
                  and angiogenesis. Distortions in blood flow result in portal hypertension.
               Genetics
               Hemochromatosis, Wilson disease, and α -antitrypsin deficiency in adults are associated with
                                                       1
               cirrhosis.

               RISK FACTORS
               Alcohol abuse, intravenous drug abuse, obesity

               GENERAL PREVENTION
                  Mitigate risk factors (e.g., alcohol abuse; screen for hepatitis C); >80% of chronic liver disease
                  is preventable.
                  Limit alcohol consumption and advise weight loss in overweight or obese patients.

               COMMONLY ASSOCIATED CONDITIONS
               HCV, alcohol and drug abuse, diabetes, depression, obesity



                      DIAGNOSIS
   1   2   3   4   5   6   7